IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: BioScrip
Symbol: BIOS
Price: Last trade $2.83
Trade Date: 6/17
Shares: 40 million
Underwriter(s) Jefferies
Rating=Subscription Needed
Company: Comtech Telecommunications Corp.
Symbol: CMTL
Price: Last trade $20.04
Trade Date: 6/17
Shares: 5 million
Underwriter(s) Citigroup, Jefferies, BMO Capital Markets, Raymond James
Co Manager(s) Northland Securities, Ladenburg Thalmann, NobleInternational Investments, Santander Investment Securities
Rating=Subscription Needed
Company: Minerva Neurosciences
Symbol: NERV
Price: Last trade $10.14
Description: No re-offer range available
Trade Date: 6/14
Shares: 3.9 million
Underwriter(s) Jefferies, JMP Securities
Rating=Subscription Needed
Company: Western Gas Equity Partners, LP
Symbol: WGP
Price: Last trade $41.74
Description: Re-offer range $38.50-$40.50
Trade Date: 6/14
Shares: 12.5 million
Underwriter(s) Goldman Sachs, Morgan Stanley
Rating=Subscription Needed
Company: Innocoll AG
Symbol: INNL
Price: Last trade $11.00
Trade Date: 6/16
Shares: 5.9 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed
Company: Viveve Medical, Inc.
Symbol: VIVE
Price: $8.00-$8.00
Description: Their common stock is currently quoted on the OTCQB under the symbol VIVMF.
Trade Date: 6/14
Shares: 1.6 million
Underwriter(s) Ladenburg Thalmann, Craig-Hallum Capital Group
Co Manager(s) Maxim Group
Rating=Subscription Needed
Company: Spark Therapeutics, Inc.
Symbol: ONCE
Price: Last trade $52.55
Trade Date: 6/15
Shares: 3.5 million
Underwriter(s) J.P. Morgan, Cowen
Rating=Subscription Needed
Company: Zimmer Biomet Holdings [NYSE]
Symbol: ZBH
Price: Last Trade $118.24
Description: Re-offer range $115.85-$116.85
Trade Date: 6/14
Shares: 11.1 million
Underwriter(s) Goldman Sachs, J.P. Morgan
Rating=Subscription Needed